Can$100m PPP established in ex-AstraZeneca facilities in Montreal
This article was originally published in Scrip
Executive Summary
AstraZeneca and Pfizer have partnered with the government of Quebec in Canada to create a new life sciences research institute that will receive an initial investment of Can$100 million over five years. The new institute resulting from the public-private partnership, NéoMed, will be based in AstraZeneca's former neuroscience research facilities at the Montreal Technoparc.